A HDAC inhibitor
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Pyroxamide

Item No. 13870

Technical Information
Formal Name
N1-hydroxy-N8-3-pyridinyl-octanediamide
CAS Number
382180-17-8
Molecular Formula
C13H19N3O3
Formula Weight
Purity
≥95%
Formulation
A crystalline solid
DMF: 2 mg/mlDMSO: 5 mg/mlDMSO:PBS (pH 7.2) (1:1): 0.5 mg/ml
λmax
203, 241, 279 nm
SMILES
O=C(CCCCCCC(NO)=O)NC1=CC=CN=C1
InChi Code
InChI=1S/C13H19N3O3/c17-12(15-11-6-5-9-14-10-11)7-3-1-2-4-8-13(18)16-19/h5-6,9-10,19H,1-4,7-8H2,(H,15,17)(H,16,18)
InChi Key
PTJGLFIIZFVFJV-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    Pyroxamide is an inhibitor of histone deacetylases (HDACs), including HDAC1 (IC50 = 0.1-0.2 μM).1,2 It induces growth suppression and cell death of certain types of cancer cells in culture.3,1

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Butler, L.M., Webb, Y., Agus, D.B., et alInhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase. Clin. Cancer Res. 7, 962-970 (2001).

    2. Remiszewski, S.W., Sambucetti, L.C., Atadja, P., et alInhibitors of human histone deacetylase: Synthesis and enzyme and cellular activity of straight chain hydroxamates. J. Med. Chem. 45(4), 753-757 (2002).

    3. Kutko, M.C., Glick, R.D., Butler, L.M., et alHistone deacetylase inhibitors induce growth suppression and cell death in human rhabdomyosarcoma in vitro. Clin. Cancer Res. 9, 5749-5755 (2003).